Vaccination deferral among children with seizures in Zhejiang: influence, recommendation, safety and implications

Chai Ji1, Mingyan Li1, Yan Zeng1

  • 1Department of Child Health Care, Children's Hospital Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.

Expert Review of Vaccines
|October 13, 2021
PubMed

Insights

Routine childhood vaccination is safe for children with seizures, despite common delays due to provider and parent hesitancy. Educating caregivers on vaccine benefits and contraindications is crucial.

Area of Science:

  • Pediatrics
  • Neurology
  • Immunology

Background:

  • Delayed childhood vaccination is prevalent in China, particularly for children experiencing seizures.
  • Seizures are often misperceived as absolute contraindications for routine immunizations.

Purpose of the Study:

  • To assess vaccination status, deferral reasons, and safety in children with seizures in Zhejiang, China.
  • To provide evidence-based recommendations for vaccinating this vulnerable pediatric population.

Main Methods:

  • A retrospective study of 1539 children with various seizure types (febrile seizure, epilepsy, etc.).
  • Data collection via questionnaires for deferral reasons and review of vaccination records and adverse events.
  • Categorization of children into febrile seizure, epilepsy, unclassified, and other symptomatic seizure groups.

Main Results:

  • Most children (95.6%) were vaccinated before seizure onset, but delays occurred post-seizure.
  • 76.1% received recommendations for normal vaccination, with febrile seizure patients having the highest proportion (90.3%).
  • 88.73% were vaccinated as recommended, with no serious adverse events or seizure exacerbations reported; provider/parent hesitation was the primary deferral reason.

Conclusions:

  • Seizures are frequently overestimated as contraindications for vaccination, leading to unnecessary delays.
  • Routine vaccination is generally safe and recommended for children with seizures.
  • Educational initiatives for healthcare providers and parents are essential to address vaccine hesitancy and ensure timely immunization.
Abstract

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
46.3K
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
362
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
522
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
682
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
41
Cross-reactivity00:42

Cross-reactivity

Overview
31.8K